Clinical Trials Logo
  1. Home
  2. Genetic Disorders
  3. NCT00262288

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Genetic Disorders Clinical Trial

Official title:
A Phase II/III Study of the Efficacy and Safety of Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Clinical Trial Summary

The purpose of this multi-center study is to explore the efficacy, safety, tolerability and pharmacokinetics/pharmacodynamics of recombinant human C1 inhibitor in the treatment of acute attacks in patients with hereditary angioedema.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00262288
Study type Interventional
Source Pharming Technologies B.V.
Contact
Status Completed
Phase Phase 2/Phase 3
Start date April 2004
Completion date January 2007
View Details
See also
  Status Clinical Trial Phase
Completed NCT00705055 - Face Anthropometric Pattern Recognition Technology for Computer Aided Diagnosis of Human Genetic Disorders. N/A
Completed NCT00851409 - A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration Phase 2
Completed NCT00262301 - Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema Phase 3
Completed NCT00261053 - Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema Phase 2
Completed NCT01902901 - Clinical Implementation of Carrier Status Using Next Generation Sequencing N/A
Completed NCT00578435 - Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of Erythropoiesis Phase 2
Recruiting NCT03911531 - Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops
Completed NCT01401257 - Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A Phase 2
Not yet recruiting NCT00214448 - Reproducibility of the Array-Based Comparative Genomic Hybridization (aCGH) System Using Whole Blood Samples N/A